tetano
Editor, Senior Moderator
MMWR Morb Mortal Wkly Rep
. 2024 Nov 21;73(46):1052-1057.
doi: 10.15585/mmwr.mm7346a2.
Coverage with Influenza, Respiratory Syncytial Virus, and COVID-19 Vaccines Among Nursing Home Residents - National Healthcare Safety Network, United States, November 2024
Hannah E Reses, George Segovia, Heather Dubendris, Kira Barbre, Sushmitha Ananth, Brynn Lape-Newman, Emily Wong, Molly Stillions, Theresa Rowe, Elizabeth Mothershed, Erika Wallender, Evelyn Twentyman, Ryan E Wiegand, Pragna Patel, Andrea Benin, Jeneita M Bell
Nursing home residents are at elevated risk for severe complications from respiratory viruses, including SARS-CoV-2, influenza, and respiratory syncytial virus (RSV). Nursing homes are required to report COVID-19 vaccination coverage and can voluntarily report influenza and RSV vaccination coverage among residents to CDC's National Healthcare Safety Network. The purpose of this study was to assess COVID-19, influenza, and RSV vaccination coverage among nursing home residents early in the 2024-25 respiratory virus season. As of November 10, 2024, 29.7% of nursing home residents had received a 2024-2025 COVID-19 vaccine. Among residents at facilities that elected to report vaccination against influenza (59.4% of facilities) and RSV (51.8% of facilities), 58.4% had received influenza vaccination, and 17.9% had received RSV vaccination. Vaccination coverage varied by U.S. Department of Health and Human Services region, social vulnerability index level, and facility size. Addressing low coverage with COVID-19, influenza, and RSV vaccines is a priority to protect residents who are susceptible to severe outcomes associated with respiratory illnesses.
. 2024 Nov 21;73(46):1052-1057.
doi: 10.15585/mmwr.mm7346a2.
Coverage with Influenza, Respiratory Syncytial Virus, and COVID-19 Vaccines Among Nursing Home Residents - National Healthcare Safety Network, United States, November 2024
Hannah E Reses, George Segovia, Heather Dubendris, Kira Barbre, Sushmitha Ananth, Brynn Lape-Newman, Emily Wong, Molly Stillions, Theresa Rowe, Elizabeth Mothershed, Erika Wallender, Evelyn Twentyman, Ryan E Wiegand, Pragna Patel, Andrea Benin, Jeneita M Bell
- PMID: 39570790
- PMCID: PMC11581205
- DOI: 10.15585/mmwr.mm7346a2
Nursing home residents are at elevated risk for severe complications from respiratory viruses, including SARS-CoV-2, influenza, and respiratory syncytial virus (RSV). Nursing homes are required to report COVID-19 vaccination coverage and can voluntarily report influenza and RSV vaccination coverage among residents to CDC's National Healthcare Safety Network. The purpose of this study was to assess COVID-19, influenza, and RSV vaccination coverage among nursing home residents early in the 2024-25 respiratory virus season. As of November 10, 2024, 29.7% of nursing home residents had received a 2024-2025 COVID-19 vaccine. Among residents at facilities that elected to report vaccination against influenza (59.4% of facilities) and RSV (51.8% of facilities), 58.4% had received influenza vaccination, and 17.9% had received RSV vaccination. Vaccination coverage varied by U.S. Department of Health and Human Services region, social vulnerability index level, and facility size. Addressing low coverage with COVID-19, influenza, and RSV vaccines is a priority to protect residents who are susceptible to severe outcomes associated with respiratory illnesses.